Phibro Animal Health Corporation
PAHC
$33.26
-$0.20-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.27% | 20.90% | 39.73% | 38.63% | 32.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.27% | 20.90% | 39.73% | 38.63% | 32.14% |
| Cost of Revenue | 8.46% | 16.84% | 37.33% | 45.23% | 29.63% |
| Gross Profit | 14.17% | 28.98% | 44.80% | 24.55% | 37.92% |
| SG&A Expenses | 14.00% | 17.02% | 16.17% | 12.54% | 14.38% |
| Depreciation & Amortization | -- | -- | -- | -20.46% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.69% | 16.89% | 31.84% | 36.52% | 25.89% |
| Operating Income | 14.45% | 50.99% | 127.49% | 60.89% | 106.60% |
| Income Before Tax | 8.84% | 652.89% | 277.00% | 272.14% | 129.75% |
| Income Tax Expenses | -5.89% | 442.41% | 268.24% | 17.10% | 95.00% |
| Earnings from Continuing Operations | 15.06% | 762.14% | 280.32% | 2,190.43% | 148.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.06% | 762.14% | 280.32% | 2,190.43% | 148.42% |
| EBIT | 14.45% | 50.99% | 127.49% | 60.89% | 106.60% |
| EBITDA | 10.81% | 41.44% | 102.38% | 56.11% | 85.01% |
| EPS Basic | 14.96% | 761.83% | 280.02% | 2,186.56% | 148.34% |
| Normalized Basic EPS | -6.42% | 161.06% | 120.35% | 141.79% | 186.09% |
| EPS Diluted | 15.69% | 752.42% | 282.35% | 2,186.56% | 145.78% |
| Normalized Diluted EPS | -7.10% | 159.78% | 118.90% | 141.24% | 184.92% |
| Average Basic Shares Outstanding | 0.08% | 0.07% | 0.07% | 0.00% | 0.04% |
| Average Diluted Shares Outstanding | 0.81% | 0.59% | 0.73% | 0.25% | 0.47% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.13% | -0.88% | -0.74% | -0.96% | -0.60% |